Showing results (121-130 of 610) with videos related to
Sort By:
Pageof 61
Analytical Biochemistry|June 1, 1997
Screening panels of monoclonal antibodies using phage-displayed antigenH R Lijnen, I Lasters, M Verstreken, et al.Blood|March 26, 1999
Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleedingH R Lijnen, K Okada, O Matsuo, et al.Journal of Thrombosis and Haemostasis : JTH|June 29, 2007
Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in miceY Suzuki, N Nagai, K Umemura, et al.Blood|July 1, 1991
Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism modelH R Lu, H R Lijnen, J M Stassen, et al.Drugs|September 1, 1989
Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agentD Collen, H R Lijnen, P A Todd, et al.Thrombosis and Haemostasis|December 1, 1996
Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activatorK Okada, H R Lijnen, H Moreau, et al.Thrombosis and Haemostasis|July 10, 1998
Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin systemH R Lijnen, J Silence, G Lemmens, et al.Thrombosis and Haemostasis|February 28, 1984
Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activationH R Lijnen, J Soria, C Soria, et al.Circulation|March 1, 1986
Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarctionD Collen, H Bounameaux, F De Cock, et al.The Journal of Biological Chemistry|January 25, 1986
Activation of plasminogen by pro-urokinase. I. MechanismH R Lijnen, C Zamarron, M Blaber, et al.Pageof 61